Antibiotics and Older-Onset IBD: Increased Risk in Adults Older Than 60
Adam S. Faye, MD, discusses his team’s research on how antibiotics increase the risk for inflammatory bowel disease among older adults and what clinicians should keep in mind.
Diagnosis & Disease Information
Rheumatoid Arthritis Likely Plays Causal Role in Inflammatory Bowel Disease
Researchers assessed whether rheumatoid arthritis is causally related to inflammatory bowel disease and vice versa.
Can Consuming Micronutrients Affect Ulcerative Colitis Risk?
Researchers examined the association between micronutrient intake and the risk for ulcerative colitis.
FDA to Review Biosimilar Hyrimoz High Concentration Formulation
The sBLA is supported by data from a phase 1 pharmacokinetics bridging study comparing Hyrimoz 50mg/mL and citrate-free Hyrimoz HCF.
Can Fecal Microbiota Transplantation Become a Standard of Care for Ulcerative Colitis?
Studies show fecal microbiota transplantation (FMT) can help patients with ulcerative colitis (UC) achieve remission, but challenges must be addressed before FMT can become a standard of treatment for UC.
Psychological Health Affects Inflammatory Bowel Disease Activity
Researchers evaluated the effects of psychological health on prognosis for inflammatory bowel disease.
Antibiotic Use Increases Risk for Older-Onset Inflammatory Bowel Disease
Researchers evaluated the effects of antibiotic exposure, specifically cumulative use, timing of use, and the association with older-onset IBD.
Fecal Microbiota Transplantation in Children With Underlying Gastric Conditions
Investigators assessed the impact of underlying comorbidities on the efficacy of fecal microbiota transplantation in children with recurrent Clostridioides difficile infection.
Rinvoq Approved for Moderately to Severely Active Ulcerative Colitis
The approval was based on data from two phase 3 induction studies and one phase 3 maintenance study.
FDA to Review Abrilada for Interchangeability With Humira
The PAS is supported by data from the REFLECTIONS B538-12 study, which assessed multiple switches between Abrilada and Humira, in addition to methotrexate, in adults with moderate to severe rheumatoid arthritis.
- Loading...
Loading...
Loading... 
Loading...